Vivo Bio Tech Balance Sheet Health
Financial Health criteria checks 3/6
Vivo Bio Tech has a total shareholder equity of ₹544.0M and total debt of ₹730.6M, which brings its debt-to-equity ratio to 134.3%. Its total assets and total liabilities are ₹1.4B and ₹827.3M respectively. Vivo Bio Tech's EBIT is ₹117.3M making its interest coverage ratio 1.5. It has cash and short-term investments of ₹13.9M.
Key information
134.3%
Debt to equity ratio
₹730.64m
Debt
| Interest coverage ratio | 1.5x |
| Cash | ₹13.90m |
| Equity | ₹544.00m |
| Total liabilities | ₹827.34m |
| Total assets | ₹1.37b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 511509's short term assets (₹472.3M) exceed its short term liabilities (₹379.1M).
Long Term Liabilities: 511509's short term assets (₹472.3M) exceed its long term liabilities (₹448.2M).
Debt to Equity History and Analysis
Debt Level: 511509's net debt to equity ratio (131.8%) is considered high.
Reducing Debt: 511509's debt to equity ratio has increased from 79.5% to 134.3% over the past 5 years.
Debt Coverage: 511509's debt is well covered by operating cash flow (21.2%).
Interest Coverage: 511509's interest payments on its debt are not well covered by EBIT (1.5x coverage).